The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.60
Bid: 92.10
Ask: 93.00
Change: -0.10 (-0.11%)
Spread: 0.90 (0.977%)
Open: 94.50
High: 94.50
Low: 91.60
Prev. Close: 92.70
HTWS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Helios Towers Announces Launch of Offer

8 Jun 2020 08:20

RNS Number : 1848P
Helios Towers PLC
08 June 2020
 

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) 596/2014

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933 (THE "U.S. SECURITIES ACT")) IN OR INTO ANY OTHER JURISDICTION OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION IN WHICH SUCH DISTRIBUTION IS UNLAWFUL

 

HELIOS TOWERS ANNOUNCES LAUNCH OF OFFER OF U.S.$425 MILLION AGGREGATE PRINCIPAL AMOUNT OF SENIOR NOTES DUE 2025

June 8, 2020 - HTA Group, Ltd. (the "HTA Group"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces the launch of its offering of fixed rate senior notes due 2025, guaranteed on a senior basis by the Company and certain of its direct and indirect subsidiaries (the "Notes"), as well as the entry into new debt facilities (the "Refinancing").

Senior Notes

The proceeds of the Notes, together with U.S.$7 million of cash on hand, will be used (i) to finance the purchase of up to U.S.$325 million aggregate principal amount of the HTA Group's outstanding senior notes due 2022 (the "Existing Notes") pursuant to the Tender Offer (as defined below), (ii) to repay all amounts outstanding under its U.S.$125 million term facility (of which, as of the date hereof, approximately U.S.$75 million was outstanding) and (iii) to pay certain fees and expenses in relation to the Refinancing and the Tender Offer.

Concurrently with this announcement, HTA Group announced a tender offer (the "Tender Offer") for up to U.S.$325 million of aggregate principal amount of the outstanding Existing Notes (the "Maximum Tender Amount") pursuant to an offer to purchase dated the same date (the "Offer to Purchase").

If the aggregate principal amount of Existing Notes validly tendered and not validly withdrawn as of the Expiration Time is less than the Maximum Tender Amount, HTA Group intends to redeem an aggregate principal amount of Existing Notes pursuant to the terms of the indenture for the Existing Notes (the "Existing Notes Indenture") (at the redemption price of 102.281% of the principal amount (plus any accrued interest)), such that no more than U.S.$275 million in aggregate principal amount of Existing Notes remains outstanding following the Tender Offer and any such redemption.

Additionally, in the event that the proceeds from the Offering are sufficient to, among other uses of proceeds, pay the redemption price of 102.281% of the principal amount (plus any accrued interest) in connection with an optional redemption of the entire aggregate principal amount of the Existing Notes outstanding pursuant to the terms of the Existing Notes Indenture, HTA Group intends to cancel the Tender Offer and issue a notice of conditional redemption immediately following such cancellation to instead redeem all outstanding Existing Notes on or about the settlement date of the New Notes Offering.

The Company entered into an agreement dated June 5, 2020 with Emerging Africa Infrastructure Fund Limited acting through its agent Ninety One SA (Pty) Ltd ("EAIF") (the "EAIF Investment Agreement") and an agreement dated June 6, 2020 with DEG-Deutsche Investitions-und Entwicklungsgesellschaft mbH ("DEG") (the "DEG Investment Agreement"), pursuant to which EAIF and DEG, respectively, have agreed to purchase a portion of the Notes as part of the initial distribution of the Notes. Subject to the terms of the EAIF Investment Agreement, EAIF will be allocated up to U.S.$60 million principal amount of Notes and, subject to the terms of the DEG Investment Agreement, DEG will be allocated up to U.S.$25 million principal amount of New Notes, with the final allocation to be determined by the Company.

New Term and Revolving Credit Facilities

HTA Group entered into a U.S.$135 million term facility (with a 5-year tenor, and which may increase in accordance with its terms up to an aggregate amount of U.S.$200 million) with borrowing availability in U.S. dollars for the general corporate purposes (including acquisitions) of the Company and certain of its subsidiaries. This new term facility will replace the existing U.S.$125 million term facility, which will be cancelled upon completion of any Notes offering.

Additionally, HTA Group entered into a revolving credit facility (with a 4.5-year tenor) with borrowing availability in U.S. dollars for the purpose of financing or refinancing the general corporate and working capital needs of the Company and certain of its subsidiaries. Commitments under the new revolving credit facility amount to 10% of the principal amount of any Notes offering (subject to a maximum of U.S.$70 million). Commitments under HTA Group's existing revolving credit facility are expected to be reduced on or about the completion of any Notes offering on a pro rata basis with the purchase or redemption of Existing Notes in the Refinancing. On or about the completion of any Notes offering, aggregate commitments under both revolving credit facilities are expected to amount to approximately U.S.$70 million.

Drawings under the new facilities are conditioned upon the closing of a Notes offering.

* * * * *

This announcement is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy the Notes or the Existing Notes, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which, or to any person to whom, such offer, solicitation or sale would be unlawful. The Notes and the guarantees in respect thereof have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction. Securities may not be offered in the United States absent registration or an exemption from registration. Accordingly, the Notes are being offered and sold only to "qualified institutional buyers" as defined in and in reliance on Rule 144A under the Securities Act and outside the United States to non-U.S. persons as defined in, and in accordance with, Regulation S under the Securities Act. No action has been or will be taken in any jurisdiction in relation to the Notes to permit a public offering of securities. There is no assurance that any Notes offering will be completed or, if completed, as to the terms on which it is completed.

The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area ("EEA") or the United Kingdom. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II") or (ii) a customer within the meaning of Directive 2016/97/EU (as amended), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the EEA or the United Kingdom has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA or the United Kingdom may be unlawful under the PRIIPS Regulation.

FCA/ICMA Stabilisation

MiFID II professionals/ECPs-only - Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA or the United Kingdom.

This announcement is being distributed to, and is directed at, only persons who (i) are outside the United Kingdom; (ii) have professional experience in matters relating to investments and who qualify as investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ''Financial Promotion Order''), (iii) fall within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Promotion Order; or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000, as amended (the ''FSMA'') in connection with the issue or sale of any Notes may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as ''relevant persons''). The investments to which this announcement relates are available only to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such investments will be available only to or will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this announcement or any of its contents. Persons distributing this announcement must satisfy themselves that it is lawful to do so.

The distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such restrictions. Any failure to comply with these restrictions may constitute a violation of the laws of any such jurisdiction.

Forward-Looking Information

Certain statements included herein may constitute forward-looking statements within the meaning of the securities laws of certain jurisdictions. Certain such forward-looking statements can be identified by the use of forward-looking terminology such as "believes", "expects", "may", "are expected to", "intends", "will", "will continue", "should", "would be", "seeks", "anticipates" or similar expressions or the negative thereof or other variations thereof or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the Company concerning, among other things, the results in relation to operations, financial condition, liquidity, prospects, growth and strategies of the Company and the industry in which it operates. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFZGGVLNNGGZM
Date   Source Headline
25th Apr 20243:40 pmRNS2024 Annual General Meeting Results
23rd Apr 20247:00 amRNSNotice of Q1 2024 Results Date & Conference Call
22nd Apr 20247:00 amRNSCredit rating upgrade
16th Apr 20242:29 pmRNSDirector/PDMR Shareholding
28th Mar 20248:57 amRNSTotal Voting Rights
25th Mar 202410:31 amRNSDoc re Annual Report and Financial Statements
20th Mar 202412:31 pmRNSDirector/PDMR Shareholding
19th Mar 20242:52 pmRNSHolding(s) in Company
19th Mar 20247:56 amRNSHolding(s) in Company
15th Mar 202412:52 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSResults for the year and quarter ended 31 Dec 2023
26th Jan 20249:00 amRNSDirectorate Change
18th Jan 20247:00 amRNSNotice of FY 2023 Results Date & Conference Call
3rd Nov 20237:05 amRNSBlock Listing Interim Review
2nd Nov 20237:00 amRNSQ3 2023 Results
16th Oct 20237:01 amRNSResults of capped tender offer
16th Oct 20237:00 amRNSResults of Tender Offer for Senior Notes
10th Oct 20237:00 amRNSNotice of Q3 2023 Results Date & Conference Call
3rd Oct 20231:29 pmRNSDirector/PDMR Shareholding
28th Sep 20231:34 pmRNSExtension of Early Tender Time
14th Sep 20237:05 amRNSNew Facilities and tender offer of Senior Notes
14th Sep 20237:00 amRNSUp to $400m Tender Offer for Senior Notes
3rd Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSNotice of H1 2023 Results Date & Conference Call
23rd May 20231:39 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirectorate Change
18th May 20237:00 amRNSQ1 2023 Results
3rd May 202311:25 amRNSBlock Listing Interim Review
27th Apr 20233:39 pmRNS2023 Annual General Meeting Results
17th Apr 20239:44 amRNSNotice of Q1 2023 Results Date & Conference Call
27th Mar 20232:16 pmRNS2022 Annual Report and 2023 Notice of AGM
16th Mar 20237:00 amRNSFinal Results
27th Jan 20237:00 amRNSNotice of FY2022 Results Date & Conference Call
15th Dec 20225:56 pmRNSHolding in Company
8th Dec 20222:55 pmRNSClosing of tower acquisition in Oman
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSUpdate on Omantel Tower Portfolio Acquisition
14th Nov 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
9th Nov 20228:53 amRNSHolding(s) in Company
3rd Nov 20227:00 amRNSQ3 2022 Results
6th Oct 20227:00 amRNSNotice of Q3 2022 Results Date & Conference Call
3rd Oct 20227:00 amRNSBlock Listing Application
29th Sep 202212:03 pmRNSOmantel Tower Acquisition Long-Stop Date Extension
18th Aug 20227:00 amRNSDirectorate Change
18th Aug 20227:00 amRNSHalf-year Report
13th Jul 20227:00 amRNSNotice of H1 2022 Results Date & Conference Call
5th Jul 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
21st Jun 202212:49 pmRNSDirector/PDMR Shareholding
17th Jun 202210:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.